These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26235581)

  • 1. Efficient Packaging of Plasmid DNA Using a pH Sensitive Cationic Lipid for Delivery to Hepatocytes.
    Sakurai Y; Matsuda T; Hada T; Harashima H
    Biol Pharm Bull; 2015; 38(8):1185-91. PubMed ID: 26235581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between a multifunctional envelope-type nano device and lipoplex for delivery to the liver.
    Yamauchi J; Hayashi Y; Kajimoto K; Akita H; Harashima H
    Biol Pharm Bull; 2010; 33(5):926-9. PubMed ID: 20460780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Multifunctional Envelope-Type Nano Device Containing a pH-Sensitive Cationic Lipid for Efficient Delivery of Short Interfering RNA to Hepatocytes In Vivo.
    Sato Y; Harashima H; Kohara M
    Methods Mol Biol; 2016; 1364():71-8. PubMed ID: 26472443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo.
    Sato Y; Hatakeyama H; Sakurai Y; Hyodo M; Akita H; Harashima H
    J Control Release; 2012 Nov; 163(3):267-76. PubMed ID: 23000694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octaarginine- and pH sensitive fusogenic peptide-modified nanoparticles for liver gene delivery.
    Khalil IA; Hayashi Y; Mizuno R; Harashima H
    J Control Release; 2011 Dec; 156(3):374-80. PubMed ID: 21864599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional enveloped nanodevices (MENDs).
    Sato Y; Nakamura T; Yamada Y; Akita H; Harashima H
    Adv Genet; 2014; 88():139-204. PubMed ID: 25409606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system.
    Sakurai Y; Hatakeyama H; Sato Y; Hyodo M; Akita H; Ohga N; Hida K; Harashima H
    J Control Release; 2014 Jan; 173():110-8. PubMed ID: 24120854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of apolipoprotein E-modified liposomal nanoparticles as a carrier for delivering DNA and nucleic acid in the brain.
    Tamaru M; Akita H; Nakatani T; Kajimoto K; Sato Y; Hatakeyama H; Harashima H
    Int J Nanomedicine; 2014; 9():4267-76. PubMed ID: 25228805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of doxorubicin efficacy using liposomal anti-polo-like kinase 1 siRNA in human renal cell carcinomas.
    Sakurai Y; Hatakeyama H; Akita H; Harashima H
    Mol Pharm; 2014 Aug; 11(8):2713-9. PubMed ID: 24800640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of an efficient short interference RNA (siRNA) delivery system with a new pH-sensitive cationic lipid].
    Sato Y; Hatakeyama H; Hyodo M; Akita H; Harashima H
    Yakugaku Zasshi; 2012; 132(12):1355-63. PubMed ID: 23208041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene silencing via RNAi and siRNA quantification in tumor tissue using MEND, a liposomal siRNA delivery system.
    Sakurai Y; Hatakeyama H; Sato Y; Hyodo M; Akita H; Harashima H
    Mol Ther; 2013 Jun; 21(6):1195-203. PubMed ID: 23568259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spleen selective enhancement of transfection activities of plasmid DNA driven by octaarginine and an ionizable lipid and its implications for cancer immunization.
    Kimura S; Khalil IA; Elewa YHA; Harashima H
    J Control Release; 2019 Nov; 313():70-79. PubMed ID: 31526828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional improvement of an IRQ-PEG-MEND for delivering genes to the lung.
    Ishitsuka T; Akita H; Harashima H
    J Control Release; 2011 Aug; 154(1):77-83. PubMed ID: 21619903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of a novel artificial gene delivery system multifunctional envelope-type nano device for gene therapy].
    Kogure K
    Yakugaku Zasshi; 2007 Oct; 127(10):1685-91. PubMed ID: 17917425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of lipid particles targeted via sugar-lipid conjugates as novel nuclear gene delivery system.
    Masuda T; Akita H; Nishio T; Niikura K; Kogure K; Ijiro K; Harashima H
    Biomaterials; 2008 Feb; 29(6):709-23. PubMed ID: 18001828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrodynamics-based procedure involves transient hyperpermeability in the hepatic cellular membrane: implication of a nonspecific process in efficient intracellular gene delivery.
    Kobayashi N; Nishikawa M; Hirata K; Takakura Y
    J Gene Med; 2004 May; 6(5):584-92. PubMed ID: 15133769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of naked DNA uptake and expression.
    Wolff JA; Budker V
    Adv Genet; 2005; 54():3-20. PubMed ID: 16096005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The systemic administration of an anti-miRNA oligonucleotide encapsulated pH-sensitive liposome results in reduced level of hepatic microRNA-122 in mice.
    Hatakeyama H; Murata M; Sato Y; Takahashi M; Minakawa N; Matsuda A; Harashima H
    J Control Release; 2014 Jan; 173():43-50. PubMed ID: 24511611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape.
    El-Sayed A; Masuda T; Khalil I; Akita H; Harashima H
    J Control Release; 2009 Sep; 138(2):160-7. PubMed ID: 19465073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octaarginine-modified multifunctional envelope-type nano device for siRNA.
    Nakamura Y; Kogure K; Futaki S; Harashima H
    J Control Release; 2007 Jun; 119(3):360-7. PubMed ID: 17478000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.